865. Metformin as a treatment of Fragile X and Phelan McDermid syndromes

I Gantois · 2026

Read 865. Metformin as a treatment of Fragile X and Phelan McDermid syndromes by I Gantois (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13556721.txt.

Description

I Gantois presents metformin as a candidate treatment for two genetic syndromes in 2026. Fragile X and Phelan McDermid syndromes both carry high rates of autism. About forty percent of children with autism do not respond to standard care.

Metformin is a common, approved diabetes drug with a long safety record. Mouse models of both syndromes, in males and females, are under study. Behavior is the main test of benefit in the work. Two signaling pathways that control protein making are also tracked. Readers see how an old, cheap drug is being checked for rare developmental disorders.

Catalog record

CREATORI Gantois
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE1 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13556721

Browse the full library · About the Tower of Babel